Oncological feasibility of laparoscopic subtotal gastrectomy compared with laparoscopic proximal or total gastrectomy for cT1N0M0 gastric cancer in the upper gastric body
- 387 Downloads
The upper gastric body is of particular interest in relation to gastrectomy because this area includes a border; that is, both distal and proximal gastrectomy for early gastric cancer can involve this area. Laparoscopic subtotal gastrectomy (LsTG) is reported to be suitable procedure compared with laparoscopic proximal and total gastrectomy (LPG, LTG), regarding postoperative nutritional status and surgical safety. However, whether LsTG is an oncologically acceptable procedure for early gastric cancer in the upper gastric body is unclear.
We analyzed 215 patients with cT1N0M0 gastric cancer limitedly located in the upper gastric body. The frequency of conversion from each intended procedure to an alternative procedure, the width of the pathological margin, the incidence of lymph node metastasis at each station and the 3-year overall survival (OS) and relapse-free survival (RFS) were evaluated.
LsTG was planned for 65 patients, and LPG for 72 and LTG for 78, respectively. Conversion to other procedures was required in about 10% of patients for whom LsTG or LPG was planned. The width of the pathological margin in patients who underwent LsTG was significantly shorter than patients who underwent the others. No patients who underwent LsTG, LPG or LTG had metastases in station no. 2 or 4sa lymph node. The 3-year OS and RFS rates of patients for whom each procedure was planned were not different.
LsTG could be an oncologically acceptable procedure for cT1N0M0 gastric cancer in the upper gastric body. LsTG could be one option for such disease.
KeywordsEarly gastric cancer Upper gastric body Laparoscopic subtotal gastrectomy Laparoscopic proximal gastrectomy Laparoscopic total gastrectomy
The authors declare that no external funding was received for this study.
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest to declare.
Human rights statement
All procedures followed were in accordance with the ethical standards of the institutional and national committees governing human experimentation and in compliance with the Helsinki Declaration of 1964 and later versions.
Informed consent or an appropriate substitute was obtained from all patients prior to their inclusion in the study.
- 4.Gong CS, Kim BS, Kim HS. Comparison of totally laparoscopic total gastrectomy using an endoscopic linear stapler with laparoscopic-assisted total gastrectomy using a circular stapler in patients with gastric cancer: a single-center experience. World J Gastroenterol. 2017;23:8553–61.CrossRefGoogle Scholar
- 5.Lu X, Hu Y, Liu H, Mou T, Deng Z, Wang D, et al. Short-term outcomes of intracorporeal esophagojejunostomy using the transorally inserted anvil versus extracorporeal circular anastomosis during laparoscopic total gastrectomy for gastric cancer: a propensity score matching analysis. J Surg Res. 2016;200:435–43.CrossRefGoogle Scholar
- 7.Nozaki I, Kurita A, Nasu J, Kubo Y, Aogi K, Tanada M, et al. Higher incidence of gastric remnant cancer after proximal than distal gastrectomy. Hepatogastroenterology. 2007;54:1604–8.Google Scholar
- 15.Kamikawa Y, Kobayashi T, Kamiyama S, Satomoto K. A new procedure of esophagogastrostomy to prevent reflux following proximal gastrectomy (in Japanese). Shoukakigeka. 2001;24:1053–60.Google Scholar
- 19.Kamiya S, Ohashi M, Ida S, Kumagai K, Nunobe S, Sano T, et al. Laparoscopic subtotal gastrectomy with a new marking technique, endoscopic cautery marking: preservation of the stomach in patients with upper early gastric cancer. Surg Endosc. https://doi.org/10.1007/s00464-018-6272-3 (Online Jun 19, 2018).
- 25.Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, et al., Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2018.6727. (Online Feb 7, 2019).